Tell Johnson & Johnson to Stop Blocking Access to Crucial AIDS Medication

Target: Johnson & Johnson

Goal: To urge Johnson & Johnson to negotiate with the Medicines Patent Pool so that the patents it currently holds on vital HIV drugs can be used to make medicines more accessible to the poorest AIDS sufferers.

Johnson & Johnson claims to be a responsible corporation dedicated to preventing the spread of HIV and giving to AIDS victims, and yet it is one of only a few pharmaceutical companies refusing to negotiate with the Medicines Patent Pool. The Medicines Patent Pool is an organization that exists to increase access to medicines for poor HIV/AIDS patients. It does this by pooling patents on important HIV medicines and licensing them out to manufacturers that create generic versions of the drugs that are more affordable for those who need it most.

Johnson & Johnson currently holds patents on some very critical (and expensive) HIV drugs. Pooling these patents with the Medical Patent Pool would make a huge difference to the poor children who need this medication. And yet Johnson & Johnson will not even negotiate. How can they claim to care about AIDS victims when they are really only looking at their bottom line?

While Johnson & Johnson does already discount its HIV/AIDS medication in sub-Saharan Africa by 85%, adding their patents to the Medical Patent Pool would reduce the cost of drugs for poor AIDS sufferers from $1000 a year to $100 a year. For some people, this could end up being a life-saving difference.

Tell the good people at Johnson & Johnson that if they care about saving lives, they will negotiate with the Medicines Patent Pool.


Dear Johnson & Johnson,

I know that you are committed to helping eradicate the HIV/AIDS epidemic and I admire all that you have done so far. But you could be helping so much more if you were willing to negotiate with the Medicines Patent Pool. The Pool, which most of your competitors are already involved with, does great work in making critical medications affordable for poor AIDS sufferers.

I am not asking you to give your drugs away for free. Patent holders who join the Medicines Patent Pool are compensated for their contributions. And since sales of HIV/AIDS medication in sub-Saharan Africa are not a very large chunk of your company’s profits, you can help a lot of people without too big of an impact on your bottom line. But for poor Africans, the impact could be life-saving.

Joining with the Medicines Patent Pool is a win-win situation for everyone involved. I urge you to negotiate with them today.


[Your Name Here]

Sign the Petition

  • Only your name will be displayed. By signing, you accept our terms and may receive updates on this and related causes.
FacebookCare2 NewsTwitterEmailShare

Leave a Reply

Your email address will not be published. Required fields are marked *


Facebook Comments


42 Signatures

  • Nikki Owen
  • Lea Faulks
  • Carri Welsh
  • Ana Maria Mainhardt Carpes
  • Darlene Roepke
  • Eveline Mutsaerts
  • Lynn Juozilaitis
  • Ann Blank
  • tam O
  • Mary-Carol Gales
1 of 4123...4
Skip to toolbar